Responsible for planning and execution of all clinical trials in the Renal Therapeutic Area

Global Head, Renal Clinical Development

Responsible for the design and implementation of clinical trialsResponsible for general support of Clinical Development initiatives within the Internal Medicine Franchise (Surgery, Critical Care and Nephrology)Responsible for KOL management related to ongoing projects

• Responsible for the scientific, clinical and commercial evaluation of licensing and acquisition opportunities for Ortho Biotech Products (and related J&J projects)• Experienced commercially in the use of business analytics and competitive intelligence, conducting market research, developing product forecasts and clinical development plans for licensing opportunities• Supervised and participated on teams evaluating licensing opportunities for compounds in multiple therapeutic areas including Anemia, Renal, CV, Oncology Supportive Care, Metabolic Disease, Thrombosis, Fibrosis, Inflammation/Immunology, Vaccines/Therapeutic antibodies and Critical Care• Member OBI/J&J Renal Licensing Team Multiple projects focusing primarily on Diabetic Nephropathy and Renal Supportive Care• Member J&J Metabolic Diseases Licensing Team• Member J&J Immune Mediated Inflammatory Disease TAOC (Therapeutic Area Operating Committee)

Field-based Medical Director in the PROCRIT® Anemia Franchise working in the Renal, Critical Care/Surgery and Virology therapeutic areas. Responsibilities included:• Scientific presentations• Clinical Trial site evaluation and support• KOL Development• Education and training of Healthcare Professionals and Sales Staff• Development of Scientific Training Materials• Presentations/leading Advisory Board Discussions• Phase IV Clinical Trial design Anemia in Diabetics with early CKD Anemia in Elderly patients with CKD• Pharmacoeconomics project(s)• Clinical liaison with OBI Marketing